Pimitespib, a Novel Heat Shock Protein 90 Inhibitor, Is Effective in Treating Renal Cell Carcinoma by Anti-angiogenetic Signaling
Anticancer Research · 2024
DOI: 10.21873/anticanres.17154 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Ryugo Teranishi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Neovascularization, Pathologic, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
- Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Osaka, Japan ttakahashi2@gesurg.med.osaka-u.ac.jp.
Zitieren
APA
Teranishi, R., Takahashi, T., Kurokawa, Y., Saito, T., Yamamoto, K., Momose, K., Yamashita, K., Tanaka, K., Makino, T., Nakajima, K., Eguchi, H., & Doki, Y. (2024). Pimitespib, a Novel Heat Shock Protein 90 Inhibitor, Is Effective in Treating Renal Cell Carcinoma by Anti-angiogenetic Signaling. Anticancer Research. https://doi.org/10.21873/anticanres.17154
Vancouver
Teranishi R, Takahashi T, Kurokawa Y, Saito T, Yamamoto K, Momose K, et al. Pimitespib, a Novel Heat Shock Protein 90 Inhibitor, Is Effective in Treating Renal Cell Carcinoma by Anti-angiogenetic Signaling. Anticancer Research. 2024. doi:10.21873/anticanres.17154
BibTeX
@article{Teranishi2024,
author = {Teranishi, Ryugo and Takahashi, Tsuyoshi and Kurokawa, Yukinori and Saito, Takuro and Yamamoto, Kazuyoshi and Momose, Kota and Yamashita, Kotaro and Tanaka, Koji and Makino, Tomoki and Nakajima, Kiyokazu and Eguchi, Hidetoshi and Doki, Yuichiro},
title = {Pimitespib, a Novel Heat Shock Protein 90 Inhibitor, Is Effective in Treating Renal Cell Carcinoma by Anti-angiogenetic Signaling},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17154}
}
EUVIMED